. Other types of mutagenesis, such as the construction of defined isogenic strains with single point mutations, are further complicated by the lack of generalized transducing phages that infect M. tuberculosis 3 . A range of techniques for constructing gene knockout or replacement mutants have been described that are designed to overcome the high level of illegitimate recombination (compared with homologous recombination) that is observed with linear dsDNA allelic exchange substrates (AESs). These include the use of long, linear dsDNA substrates 4 , as well as various plasmid-and cosmid-based strategies [4] [5] [6] [7] [8] , and these are often coupled with the use of counter-selectable genetic markers, such as sacB 9, 10 . Specialized transducing phages that are based on conditionally replicating shuttle phasmids represent an alternative and highly effective approach to mutagenesis 11 , including the construction of isogenic M. tuberculosis strains that differ by a single known point mutation 12 . Although most of these methods are effective, they are constrained by the requirement for complex genetic constructions and/or multiple steps of manipulation and screening. Given the slow growth rate of M. tuberculosis (doubling time of 24 hours), alternative methods that simplify its genetic manipulation are highly desirable.
Recombineering -genetic engineering using recombination proteins 13 -is a powerful system for mutagenesis in Escherichia coli (as well as species of Salmonella and Shigella 14, 15 ), in which recombination systems encoded by the λ Red system or the recE and recT genes of the Rac prophage greatly enhance the frequencies of homologous recombination. These high recombination efficiencies can be exploited in various ways, including the construction of chromosomal gene knockouts, point mutations, deletions, small insertions, in vivo cloning, mutagenesis of bacterial artificial chromosomes and genomic libraries 13, [16] [17] [18] [19] . Only short segments (50 bp) of DNA homology are required, and mutagenic substrates constructed by PCR can be readily introduced by electroporation into E. coli strains that express the phage recombination proteins.
Recombineering in E. coli using the λ Red system involves three phage-encoded proteins, Exo, Beta and Gam, whereas the Rac prophage encodes only RecE and RecT, which are functionally equivalent to λ Exo and Beta, respectively 20, 21 (FIG 1a) .
Exo and RecE are 5′→3′ exonucleases that degrade a single strand of a linear dsDNA substrate 22, 23 , thereby exposing a 3′ singlestranded DNA (ssDNA) tail to which Beta or RecT can bind 24, 25 . Recombination is then mediated by association of these complexes with resident chromosomal or plasmid targets through the pairing of complementary sequences, strand exchange or strand invasion [26] [27] [28] [29] . λ Beta and RecT proteins are members of a large family of ssDNA annealing proteins (SSAPs) 30 ; two other families of SSAPs that function similarly are defined by Salmonella phage P22 (P22) Arf and the eukaryotic protein, Rad52. Although the RecE and RecT and λ Red systems confer similar levels of recombination in E. coli, the Beta and RecT proteins have a strong preference for their cognate Exo and RecE proteins, and it is likely that they function as protein complexes 31, 32 . E. coli dsDNA recombineering requires both an exonuclease and its associated SSAP, whereas recombination using ssDNA substrates requires only the SSAP. The ability to recombineer with short, oligonucleotide-derived ssDNA substrates is especially useful 19 , and frequencies can be sufficiently high to enable identification of mutants without the need for direct genetic selection, especially when using strains that are defective in mismatch repair 33 . The third protein in the λ system, Gam, increases recombineering frequencies by binding to the RecB subunit of RecBCD and inhibiting the degradation of dsDNA substrates 18, 19, 34, 35 . Although other Gam functional analogues have been characterized, such as Abc2 of P22 (ReF. 36) , these proteins are rare compared with the large superfamilies of SSAPs and their associated exonucleases 30 . mycobacteriophages have helped us to circumvent some of the major challenges of genetics in M. tuberculosis, including shuttle-phasmid development 37 for transposon mutagenesis 38 , reporter-gene delivery 39, 40 and specialized transduction 11 , as well as the production of integration-proficient vectors for stable introduction of foreign genes [41] [42] [43] [44] . Exploitation of these phages has been simplified by the complete sequencing of more than 50 mycobacteriophage genomes [43] [44] [45] [46] , and the high level of genetic diversity discovered has provided us with at least 1,500 phamilies of unique genes. Because the E. coli-based systems seem to function less well in distantly related bacteria, we turned to this collection of mycobacteriophage genomes to identify mycobacteriophageencoded proteins that could be developed for mycobacterial recombineering. Although RecE and RecT homologues are rare among mycobacteriophages, mycobacteriophage Che9c (Che9c) encodes both proteins, and we have exploited these proteins to develop recombineering systems for both fast-and slow-growing mycobacteria 47, 48 . This approach also provides a powerful strategy for constructing mutant derivatives of lytically replicating mycobacteriophage genomes, including inframe deletions, point mutations and small insertions.
Identification of recombineering functions mycobacteriophages are genetically diverse, possess architecturally mosaic genomes [43] [44] [45] [46] 49 and are replete with predicted open reading frames of unknown function that have no detectable similarity to known proteins. while constructing shuttle-phasmid derivatives of mycobacterium phage Tm4 (Tm4), Jacobs and colleagues 37 noted a high prevalence of recombinants following electroporation of phage libraries into Mycobacterium smegmatis, suggesting the presence of a phage-encoded recombination system. However, bioinformatic analysis of the Tm4 genomic sequence 50 provides no clues as to which genes might encode recombination functions.
A search of the predicted open reading frames of all completely sequenced mycobacteriophage genomes reveals a small number of homologues of the E. coli RecE and RecT proteins but none that is related to the λ Red proteins. Che9c encodes for homologues of both RecE and RecT, the products of genes 60 and 61, respectively 46, 47 (FIG. 1a) ; both are distant relatives and share less than 30% amino-acid identity. Che9c gene product 60 (gp60; 314 amino acids) is also smaller than E. coli RecE (866 amino acids) and corresponds to the carboxy (C)-terminal part that encompasses the RecB-family nuclease domain (FIG. 1a) ; the amino (N)-terminal region of RecE that is absent in Che9c gp60 is not necessary for RecE exonuclease activity 51 . Che9c gp61 shares 29% amino-acid identity with E. coli RecT, and is therefore clearly a member of the 60 (gp60) and gp61 are Escherichia coli rac prophage recE and rect homologues, respectively. Mycobacteriophage Halo encodes a recE homologue, whereas mycobacteriophage Giles gp52 belongs to the YqaJ family of exonucleases. Halo gp43 is similar to Giles gp53, but these are only distantly related to other phage rect-like proteins. the λ red recombination proteins are not closely related to the mycobacteriophage proteins or the recE or rect proteins. None of the mycobacteriophages or the E. coli rac prophage encodes a λ Gam homologue (blue). b | Electron micrographs of Che9c gp61 protein multimers in the presence of single-stranded DNA (ssDNA). reaction mixtures that contain gp61 protein (1.2 µM) incubated with ssDNA (100 nucleotides; 2 µM) were adsorbed to glow discharged 400 mesh formvar carbon-coated copper grids, stained with 2% uranyl acetate, and examined by transmission electron microscopy. Four examples of torroid structures are shown; images were collected at a magnification of x140,000 (bottom). (FIG. 1a) . Although Che9c gp60 and gp61 are distant relatives of RecE and RecT and the λ Exo and Beta proteins, they possess similar biochemical functions 47 . Che9c gp60 has exonuclease activity in vitro that is dependent on the presence of dsDNA ends, and Che9c gp61 binds short (20 nucleotides) ssDNA as well as dsDNA substrates in the absence of mg 2+ . Che9c gp61 was also observed to form toroidal multimers in the presence of ssDNA by electron microscopy (J.C.v.K. and G.F.H., unpublished observations; FIG. 1b), a property exhibited by other SSAPs 52, 53 . Two other mycobacteriophages, mycobacteriophage Halo (Halo) and mycobacteriophage Giles (Giles), encode similar recombination systems. Halo gp42 is 46% identical to Che9c gp60 and 30% identical to RecE, whereas Giles gp52 contains a domain from the YqaJ family of phage-encoded exonucleases (FIG. 1a) . However, even though Halo gp43 and Giles gp53 are 30% identical, they are even more distantly related to other phage-encoded RecT homologues than Che9c gp61 (FIG. 1a) . interestingly, a prophage in the sequenced genome of Mycobacterium avium strain 104 also encodes RecE and RecT-like proteins (mAv_0830 and mAv_0829, respectively) that are similar to Che9c gp60 and gp61 (41% and 29% identical) and are also related to the Rac prophage proteins RecE and RecT (23% and 40% identical). Thus, although in each case the mycobacteriophage putative SSAP proteins are associated with a gene that encodes an exonuclease, these systems exhibit the same modularity observed in most other phage genomes 54 . None of these mycobacteriophage systems encodes homologues of the λ Gam protein, and it is unknown if there are any mycobacteriophage functional analogues that are RecBCD inhibitors similar to the Abc2 protein of P22.
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Construction of recombineering strains mycobacterial strains have been constructed for recombineering with both dsDNA and ssDNA substrates. These contain an extrachromosomal plasmid in which the phage recombination genes are under the control of an inducible acetamidase promoter 55 , and the most widely used configurations use the Che9c genes 60 and 61 for dsDNA Plasmids pJv53 and pJv62 either express both Che9c gene products 60 (gp60) and gp61 or only gp61 to facilitate double-stranded DNA (dsDNA) and single-stranded DNA (ssDNA) recombination, respectively. Gene knockouts are made by targeted gene replacement with a linear dsDNA allelic exchange substrate (AEs) that contains 500 bp of homology to the target locus that flanks an antibiotic resistance gene (left; for example, hygromycin resistance (hyg R )). Mycobacteriophage mutants (either point mutants or deletion mutants) are made by synthesizing a 200 bp dsDNA AEs by PCr using a 100 nucleotide (nt) template and extender primers (75 nt) that contain 25 nt homology to the template and 50 nt extension at the 5′ end (middle). Point mutants are constructed by synthesizing a 50-70 nt ssDNA substrate and centring the desired point mutation, which will anneal to the lagging strand to allow DNA replication to undergo recombination. An asterisk represents the point mutation. 
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Number of cfu recombineering 47 and only Che9c 61 for ssDNA manipulations 48 . Optimal levels of recombination are obtained using plasmid derivatives that express Che9c genes 60 and 61 from their endogenous translational signals (for example, pJv53), although it should be noted that the higher levels of expression of some alternative constructions do not necessarily provide higher levels of recombineering 47 . This has also been observed for the λ Red system, the recombination activity of which correlates poorly with expression levels, particularly for the exonuclease 32 . Plasmid pJv53 serves as a basic recombineering plasmid for regulated expression of gp60 and gp61 (FIG. 2) , although other derivatives of this plasmid have been made, including those with different selectable markers or those with a sacB cassette to simplify removal of the plasmid by counterselection following mutagenesis (plasmid pJv48). The acetamidase promoter is 'leaky', and there is a detectable level of Che9c gp61 expression in M. tuberculosis in some strains that are not induced, although recombination frequencies are low without induction 47 . High expression levels of these proteins are toxic to M. smegmatis, and plasmids in which the constitutive Mycobacterium bovis BCG hsp60 promoter is linked to Che9c 60 and 61 do not transform mycobacteria. This toxicity seems to be derived mainly from the Che9c gp60 exonuclease, as plasmids that express only gp61 constitutively are tolerated, although they grow slowly. For ssDNA recombineering, plasmids such as pJv62 (FIG. 2) have been constructed that express gp61 using its own translation signals and the acetamidase promoter. in preparation for recombineering experiments, M. smegmatis or M. tuberculosis strains that contain a plasmid are induced in mid-logarithmic growth with acetamide and harvested for electroporation 47, 48 . Alternatively, M. tuberculosis strains can be grown in standard medum, washed into induction medium and incubated for 24 hours to induce expression before harvesting. This protocol yields similar recombineering frequencies, but reduces the total number of cells owing to losses during the washing steps (J.C.v.K., l.J.m. and G.F.H., unpublished observations).
Constructing gene replacements
Targeted gene-replacement mutants can be readily constructed by electroporation of linear dsDNA substrates into either M. smegmatis or M. tuberculosis recombineering strains (FIG. 2) . The AESs typically contain regions of homology upstream and downstream of the target gene that flanks a cassette for antibiotic resistance, such as the hygromycin resistance cassette (hyg R ). Although SSAP recombinases, such as gp61, can bind short regions of ssDNA, the frequency of recombineering is considerably lower with 50 bp than with 500 bp of homology, and with shorter lengths the DNA-uptake frequency becomes limiting; we therefore recommend using a minimum of 500 bp of homology 47 . A simple protocol entails transformation of electrocompetent mycobacterial cells that contain pJv53 and are induced for gp60 and gp61 expression with 100 ng of a linearized AES 47, 56 . This typically yields 50-200 drug-resistant colonies of which >90% contain correctly targeted gene replacements for both M. smegmatis and M. tuberculosis; control transformations using 50 ng plasmid DNA with the same competent cells typically yield approximately 1x10 5 colonies. Similar frequencies are observed when extrachromosomal plasmids are targeted, emphasizing the need to ensure that DNA with potential similarity to the pJv53 plasmid backbone (such as the E. coli origin of replication) is removed from the AES substrate. The AES can be generated using either PCR or restriction digests to remove the plasmid backbone; if using restriction digests, using enzymes with incompatible sites can prevent re-circularization of the plasmid and undesired insertional duplication. AESs can also be designed to subsequently unmark mutants; for example, by including γδ resolvase sites that flank the antibiotic resistance cassette and a sacB cassette for counter selection 11 . The dsDNA recombineering frequencies seem to be limited primarily by poor DNA-uptake efficiencies of mycobacteria rather than poor protein expression or DNA degradation by host nuclease systems. with either M. tuberculosis 57 or a highefficiency-transformation M. smegmatis strain 58 competencies as high as 1-5 x 10 6 transformants per µg of plasmid DNA can be achieved 47, 59 , but only 1 viable cell in 1,000 takes up DNA productively. inactivation of the M. smegmatis recBCD system only modestly increases dsDNA recombineering frequencies, and expression of λ Gam does not influence the recombineering frequencies in any strain background that we have tested (J.C.v.K. and G.F.H., unpublished observations). in practice, the recombination and DNA-uptake frequencies with the Che9c system yield sufficient recombinants for the construction of targeted genereplacement mutants in both M. smegmatis and M. tuberculosis.
Construction of point mutations
Recombineering using ssDNA substrates offers a simple method for constructing point mutations in mycobacterial genomes 48 . The overall efficiency of ssDNA recombineering is substantially higher than with dsDNA substrates for both chromosomal and plasmid targets. moreover, the exonuclease function (Che9c gp60) is not required for ssDNA substrates, and strains that contain plasmid, such as pJv62 (FIG. 2) , are suitable 48 . in ssDNA recombineering, a choice needs to be made as to which DNA strand to target. in mycobacterial recombineering this is a crucial issue, as ssDNA substrates that target the same sequence, but on different strands, can differ in recombineering efficiencies by up to 10,000-fold 48 ; this exceeds by far the 2-50-fold strand biases observed in the λ Red system 19, 31 . Recombination frequencies are always higher using a ssDNA substrate that anneals to the template for discontinuous DNA synthesis (lagging strand), presumably owing to the greater availability of ssDNA chromosomal DNA Figure 3 | mutagenesis of mycobacterial genomes. recombinases (single-stranded DNA (ssDNA) annealing proteins (ssAPs)) were assayed for ssDNA recombineering activity in Mycobacterium smegmatis by their ability to introduce streptomycin-resistance (rpsL K43r) and ofloxacin-resistance (gyrA A91v) mutations. ssAP genes are expressed from the acetamidase promoter and translationally fused to the pLAM12 vector 47 rather than using their native translation-initiation signals 48 . the number of drug-resistant colony forming units (cfu) obtained for each drug target is shown. Nature Reviews | Microbiology for pairing with gp61-ssDNA substrate complexes. it is not clear why the biases are so much larger in mycobacteria than in E. coli, but it may reflect fundamental differences in the DNA replication systems or in how gp61 interacts with the replication machinery. Substrates as short as 48 nucleotides provide optimal recombination frequencies, and this recombination is also independent of host RecA functions 48 . A simple experiment to test for ssDNA recombineering uses an oligonucleotide substrate to introduce a chromosomal point mutation that confers drug resistance. in a typical experiment that uses an oligonucleotide to target the lagging strand, 100 ng of ssDNA yields a similar number of drugresistant colonies as that obtained using 100 ng of extrachromosomal plasmid DNA (~10 5 colonies) in M. smegmatis; this frequency is lower in M. tuberculosis (fivefold to tenfold). Thus, in contrast to dsDNA recombineering, a high proportion of cells that take up ssDNA undergo recombination. The question then arises as to whether the overall frequency is high enough to construct point mutations that cannot be directly selected, bearing in mind that 99.9% of cells do not take up DNA.
This problem can be conveniently circumvented using a counter-selection strategy, in which a plasmid is co-transformed with the ssDNA and plasmid transformants are selected; this effectively counter selects against non-competent cells in the population. The transformants can then be examined by PCR, and we have found the mismatch amplification mutation assay (mAmA) PCR 60, 61 that selectively amplifies the mutant allele to be particularly effective. in our experience with M. smegmatis, 5-10% of the plasmid transformants also contain the newly introduced point mutation; the frequencies in M. tuberculosis are also slightly lower using this technique. A similar outcome can be achieved using a doubleoligonucleotide configuration, in which two ssDNA substrates are used in the same electroporation: one introduces the desired point mutation in the chromosome, whereas the other repairs a mutant hyg R gene that is present on the recombineering plasmid. The proportion of Hyg R colonies that contain the point mutation is lower (~3%), but can still be readily identified by mAmA PCR; the advantage is that only a single plasmid subsequently needs to be removed from strains for further analyses. A plasmid (pJv128) has been constructed that contains Che9c gp61 fused to the acetamidase promoter, a Kan R selectable marker, a mutated hyg R gene and a sacB counter-selectable gene for this purpose 48 . This counter-selection strategy can also be used to make unmarked deletions with dsDNA substrates, and we have successfully constructed a deletion of the M. smegmatis leuD gene using a 200 bp dsDNA substrate with 100 bp leuD homology on each side of the deletion (J.C.v.K. and G.F.H., unpublished observations). The optimal parameters for making deletions -other than the requirement for dsDNA substrates instead of ssDNA substrates -have not yet been analysed, but could include the effects of deletion length and substrate length on recombineering efficiencies, and thus far this method has only been tested in M. smegmatis. However, we think this will be an important addition to the mycobacterial recombineering technology, particularly for the construction of vaccine strains for which antibiotic resistance genes should be avoided.
An intriguing use of the ssDNA recombineering technology is the study of mutations that confer antibiotic resistance. This has been shown by introducing several well characterized point mutations that confer resistance to isoniazid, rifampicin, streptomycin and ofloxacin in M. smegmatis, as well as rifampicin and streptomycin in M. tuberculosis 48 . Recombineering with ssDNA thus offers a simple approach that allows us to determine whether any point mutation identified in a clinical strain of M. tuberculosis contributes to its drug-susceptibility profile.
Identification of phage recombinases
Although homologues of known recombinases are rare in mycobacteriophages, the Halo gp43 and Giles gp53 proteins are candidates for recombination activity (FIG. 1a) . introduction of point mutations that confer drug resistance by ssDNA recombineering provides a simple assay for testing these mutations as well as SSAPs from non-mycobacteriophage sources, including λ Beta and RecT (FIG. 3) . Halo gp43 is less active than Che9c gp61, and Giles gp53 is even less active than both Halo gp43 and Che9c gp61, which further illustrates the usefulness of a large reservoir of phage genomes to optimize potential genetic tools 48 . Anecdotal reports that the λ Red system functions poorly in mycobacteria are confirmed by the low activity of λ Beta. RecT works well, however, in M. smegmatis (FIG. 3) , although its activity is still reduced compared with Che9c gp61. Related studies report that Che9c gp61 performs poorly in E. coli ssDNA recombineering assays 62 . The molecular basis for differing activities of SSAPs is not clear, although an intriguing possibility is that they act by interacting directly with the host DNA-replication machinery.
Mycobacteriophage mutations
Constructing mutant derivatives of bacteriophages is often more difficult than manipulating the host chromosome, mostly because drug selection is not useful in lytically propagated viruses. Currently, the most powerful method for manipulating mycobacteriophages is through the construction of shuttle phasmids 63 . However, although such plasmids have many applications, they are of only limited use for determining phage gene functions. in one example, Tm4 shuttle phasmids were used to make mutations in the Tm4 tape measure gene, which allowed mutagenesis to be performed in E. coli (by λ Red recombineering) and the mutant phage to be recovered in M. smegmatis 64 . However, most mycobacteriophage genomes are too large for shuttlephasmid construction, and this approach is not broadly applicable for functional genomic studies on mycobacteriophages. A homologous recombination approach was used to construct a fire-fly luciferase recombinant of mycobacterio phage l5 (ReF. 65) , but the frequency of host-mediated recombination was so low that construction was inefficient and time-consuming. mycobacterial recombineering can be used to manipulate prophages, but is not generally applied because few mycobacteriophages form stable lysogens. The mycobacterial recombineering systems described above offer potentially powerful approaches for the construction of mutants of any lytically growing mycobacteriophage. Recombineering of phage genomes has been described for E. coli phages, such as the E. coli phage λ (lambda), using a strategy in which bacterial cells are infected with phage, competent cells are prepared, dsDNA or ssDNA substrate is introduced by electroporation and plaques are analysed for the presence of the mutation 66 . Because the frequency of DNA uptake in mycobacteria is substantially lower than the efficiency of phage infection, we have adopted an alternative approach that is based on the co-selection methods described above. Although these initial experiments are still being developed, they could be a highly effective approach for mycobacteriophage functional genomics (l.J.m. and G.F.H., unpublished observations).
The scheme we have developed for mycobacteriophage mutagenesis is shown in FIG. 4 . An M. smegmatis strain that carries a recombineering plasmid, such as pJv53 or pJv62 (FIG. 2) , is induced with acetamide and electrocompetent cells are prepared. Electroporation is performed with two DNAs: phage genomic DNA of the virus to be manipulated and a PCRgenerated or synthetic DNA substrate. Plaques are recovered in an infectious centre assay (before lysis) such that cells that have taken up phage DNA give rise to plaques on a lawn of M. smegmatis plating cells; approximately 100 plaques are obtained from 50-100 ng of phage DNA in such an experiment. All plaques contain wild-type phage DNA, but 10-40% also contain the mutant allele and can be easily identified by PCR screening of 12-18 individual plaques. Provided that the deleted region is non-essential for phage growth, purified mutant phage derivatives can be isolated by plating serial dilutions of the mixed plaques and PCR analysis of the purified plaques (FIG. 4) . Typically, analysis of 10-18 isolated plaques from this plaque purification is sufficient to identify a homogenously mutant isolate.
we have used phage recombineering to manipulate several different mycobacteriophage genomes and to generate gene knockouts, in-frame internal deletions, point mutations and small insertions. when constructing deletion mutants, we have found that a higher proportion of primary plaques contain the desired mutant allele when using dsDNA substrates than when using ssDNA substrates. larger dsDNA substrates (200 bp) also seem to work better than shorter ones (100 bp) as with mycobacterial chromosomal recombineering 47 . we have also adapted this approach to determine whether mycobacteriophage genes are required for lytic growth. in one experiment, we used a 200 bp dsDNA substrate to generate a deletion in the lysin A gene of Giles that seemed to be an essential function. PCR analysis showed that approximately 30% of the initial plaques recovered contained mutants, but when lysates were prepared after the re-plating of these mixed plaques, the mutant allele could not be identified even using a sensitive mAmA PCR approach (discussed above). we conclude that the gene is essential for the growth of Giles, and that the mutation could be constructed and the mutant propagated in the presence of wild-type phage that acts as a helper phage in the primary plaque, even though single particles do not give rise to plaques in the secondary plating. The full usefulness of these approaches for mycobacteriophage mutagenesis has perhaps yet to be realized, but the ability to modify mycobacteriophage genomes using mycobacterial recombineering will, for the first time, allow us to use broad functional genomic studies on mycobacteriophages.
Development of recombineering systems
The ability to stimulate homologous recombination in both slow-and fastgrowing mycobacteria by expressing mycobacteriophage-encoded recombination systems could be exploited in various ways. First, it seems likely that the same approaches could be used to manipulate a range of mycobacterial species other than those described here (M. smegmatis and M. tuberculosis), including other bacterial species that are closely related to mycobacteria. Second, the high efficiencies of chromosomal recombineering could facilitate the construction of ordered gene knockout or replacement mutants, particularly because the identification of mutants by PCR is compatible with genome-wide robotic strategies. last, the coupling of efficient point mutagenesis with mycobacterial nonsense suppressor strains 67 is a simple method that could allow us to produce conditional lethal mutants in mycobacterial genomes and their phages.
